Artivion AORT
NYSE AORT
$27.96 -0.86 (-2.98%)
As of: Aug 20, 2026 · 3:59 PM EDT

Artivion (AORT) Net Equity Issued and Repurchased (2010 - 2026)

Artivion's (AORT) quarterly Net Equity Issued and Repurchased came in at $1.2 million in Q1 2026, down 70.1% YoY from $4.2 million in Q1 2025, and down 63.88% on a QoQ basis from $3.5 million in Q4 2025.

Artivion (AORT) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

Artivion (AORT) has 17 years of Net Equity Issued and Repurchased data on file, last reported at $1.2 million in Q1 2026.

  • Quarterly Net Equity Issued and Repurchased fell 70.1% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.1 million (up 58.96% YoY) and the FY2025 annual result came in at $13.1 million, up 128.25% from the prior year.
  • Net Equity Issued and Repurchased fell to $1.2 million in Q1 2026, from $3.5 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $5.2 million in Q3 2025 to a low of $24000.0 in Q4 2022.
  • A 5-year average of $1.8 million and a median of $1.2 million in 2026 frame the typical range for Net Equity Issued and Repurchased.
  • Annual changes were most pronounced in 2022 — Net Equity Issued and Repurchased slumped 89.33% — and 2023, when it surged 1933.33%.
  • Tracing AORT's Net Equity Issued and Repurchased over 5 years: stood at $24000.0 in 2022, then surged by 1933.33% to $488000.0 in 2023, then fell by 9.22% to $443000.0 in 2024, then jumped by 681.26% to $3.5 million in 2025, then plunged by 63.88% to $1.2 million in 2026.
  • The last three Net Equity Issued and Repurchased figures came in at $1.2 million (Q1 2026), $3.5 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -
10 Artivion 1.36 Bn 1.28 Bn 80.52 Mn 1.38 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.38 Mn
Jun 30, 2026 1.38 Mn
Mar 31, 2026 1.25 Mn
Mar 31, 2026 1.25 Mn
Dec 31, 2025 3.46 Mn
Dec 31, 2025 3.46 Mn
Sep 30, 2025 5.15 Mn
Sep 30, 2025 5.15 Mn
Jun 30, 2025 278,000.00
Jun 30, 2025 278,000.00
Mar 31, 2025 4.18 Mn
Mar 31, 2025 4.18 Mn
Dec 31, 2024 443,000.00
Dec 31, 2024 443,000.00
Sep 30, 2024 1.70 Mn
Sep 30, 2024 1.70 Mn
Jun 30, 2024 59,000.00
Jun 30, 2024 59,000.00
Mar 31, 2024 3.53 Mn
Mar 31, 2024 3.53 Mn